For a top five pharmaceutical company, the launch of a newly acquired chronic disease therapy meant entering a therapeutic area where the organization had little prior experience. Launch timelines were compressed, and expectations were high. Medical affairs and commercial teams worked together to co-develop a launch strategy, but like many large organizations, they relied on traditional segmentation models and siloed data sources.
At launch, the company expected prescriptions to come from endocrinologists and primary care providers. But within the first weeks on market, Within3’s Launch Intelligence™ platform revealed a surprising insight that required an immediate pivot.
Business Challenges & Goals
- Compressed timeline: The company needed to deliver ROI quickly after acquisition.
- Unfamiliar market: Teams lacked infrastructure and historical expertise in the therapeutic area.
- Traditional assumptions: The launch plan focused only on expected prescribers such as PCPs and specialists.
The goal was to identify and act on insights early enough to make a measurable difference in adoption.
Insights & Actions
By unifying referral data, online discussions, and internal field insights into a single view, Within3’s AI-driven platform surfaced signals that humans alone would have missed in time:
- Referral anomalies showed unexpected patient flows that didn’t match the company’s initial assumptions.
- Digital chatter revealed that psychiatrists and therapists were actively discussing the therapy and, in some cases, initiating treatment conversations.
The implication was clear: mental health professionals were playing a much larger role in the care journey than anticipated. Patients with chronic disease were often experiencing depression and seeking support from these providers, who in turn researched the therapy and helped guide patients toward treatment decisions.
With this discovery, the company was able to:
- Expand medical education efforts to include psychiatrists and therapists.
- Adjust field strategy to engage this newly identified audience.
- Ensure patients could access therapy earlier, without waiting for multiple layers of referrals.
Business Results & Metrics
The pivot yielded measurable benefits:
- Protected the launch window: Insights surfaced in real time, avoiding the 6+ month delay typical of ATU studies.
- Accelerated ROI: Early recognition of mental health professionals as prescribers helped the therapy gain traction faster.
- Improved patient access: Patients could begin therapy sooner, guided by providers they trusted.
- Cross-functional agility: Medical and commercial teams quickly realigned to seize the opportunity.
“If they didn’t have a platform surfacing that signal, maybe eventually they would have figured it out — but it would have been a while. You only launch once, and you don’t have time to wait.”
– Lance Hill, CEO, Within3
Conclusion
This case study illustrates the power of real-time Launch Intelligence™ to uncover hidden influencers in the patient journey. By identifying the unexpected role of mental health professionals, the company was able to pivot its strategy at the most critical moment, protecting its launch investment and ensuring faster patient access.
With AI-powered analytics and a single source of truth, Within3 helped transform a high-stakes launch into a confident, data-driven success.
Ready to see the difference Launch Intelligence™ can make?
Book a demo with our team to learn more.
